MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2026 International Congress

    Treatment Patterns in Adults with Isolated Dystonia in the United States

    M. Oldham, J. Kerner, S. Dasgupta, J. Imperato, J. Thornton (Cambridge, USA)

    Objective: To characterize real-world treatment patterns in adults with isolated dystonia in the United States. Background: Isolated dystonia is a rare, complex movement disorder characterized…
  • 2026 International Congress

    Long‑term dose-effect patterns with incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in cervical dystonia: multicenter real‑world analysis

    B. Waeschle, P. Albrecht, J. Lee, T. Kölsche, R. Jansen, P. Sobolewski, S. Sánchez Valiente, E. López Valdés, P. Mir, S. Jesús, E. Ojeda Lepe, E. Papuć, P. Sánchez Alonso, G. Salazar, G. Comes, H. Stark (Frankfurt, Germany)

    Objective: To characterize long‑term dose-effect patterns for incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in cervical dystonia (CD) using a unified dose-effect parameter (DEff) and to compare complex‑free…
  • 2026 International Congress

    Rare Observations of Sustained Symptomatic Improvement with Botulinum Toxin Type A Injections in Facial and Cervical Dystonia: Case Series

    N. Rozenberg, G. Yahalom, D. Segal, L. Barski, V. Livneh, A. Ezra, R. Alcalay, T. Gurevich (Tel Aviv, Israel)

    Objective: To describe prolonged improvement in patients with involuntary facial and cervical movements after BTX-A therapy. Background: ​​​​​​ Botulinum toxin type A (BTX-A) treatment is considered…
  • 2026 International Congress

    Phasic Hemidystonia Secondary to Cavernoma: A Case of Sustained Response to Botulinum Toxin

    N. Tahsin, D. Dash, A. Elavarasi (Limerick, Ireland)

    Objective: To report a rare case of lentiform nucleus cavernoma with phasic-predominant hemidystonia and sustained BoNT response. Background: Cerebral cavernomas rarely present with movement disorders.…
  • 2026 International Congress

    Are All Toxins Created Equal? Real-world analysis of Abo-, Inco- and Ona- BoNT-A from prospective LIVEchart over 7 years

    R. Ellis, A. Moore (Liverpool, United Kingdom)

    Objective: To compare dosing, duration of action, and patient-reported outcomes across inco-, abo- and ona- BoNT (botulinum toxin) in cervical dystonia (CD), hemifacial spasm (HFS),…
  • 2026 International Congress

    Predictors of Secondary Non-Response to Botulinum Neurotoxin Type-A in Cervical Dystonia: A Multi-Center Egyptian Study

    E. Abed (Cairo, Egypt)

    Objective: To investigate clinical and treatment predictors of SNR in Egyptian CD patients receiving BoNT-A therapy. Background: Secondary non-response (SNR) to botulinum neurotoxin type-A (BoNT-A)…
  • 2026 International Congress

    Deep Brain Stimulation for Focal Abdominal Dystonia

    C. França, P. Kimaid, A. Moreira, F. Godinho (São Paulo, Brazil)

    Objective: To describe the results of bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) in a patient with early-adulthood-onset sporadic focal subacute progressive action-induced…
  • 2026 International Congress

    Early Manifestations of Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS) Include Dystonic Laryngeal Phenomena

    O. Chan, N. Simon, S. Tisch (Sydney, Australia)

    Objective: To describe four patients in whom laryngeal dystonia manifesting as cough and spasmodic dysphonia preceded Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS)…
  • 2026 International Congress

    Botulinum toxin treatment patterns and outcomes in head and neck dystonia: experience from a tertiary, multidisciplinary clinical service

    R. Everitt, R. Aggarwal, R. Mcdonagh, C. Kobylecki (Salford, United Kingdom)

    Objective: To evaluate outcomes following Botulinum toxin (BoNT) treatment for head and neck dystonia in a tertiary multidisciplinary clinic, characterise adverse effects and identify treatment…
  • 2026 International Congress

    Short Term Effects of Wearable Vibrotactile Stimulation in Laryngeal Dystonia

    N. Doan, K. Vo, T. Dang, U. Ha, T. Nguyen, T. Tran (Ho Chi Minh City, Viet Nam)

    Objective: To evaluate the short-term efficacy of a wearable vibrotactile stimulation (VTS) device in patients with laryngeal dystonia (LD) prior to botulinum toxin (BoNT) injection,…
  • 1
  • 2
  • 3
  • …
  • 23
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley